|
G |
Abca13 |
ATP binding cassette subfamily A member 13 |
decreases expression |
ISO |
kojic acid results in decreased expression of ABCA13 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr14:88,087,146...88,589,868
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of ABCC2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABCC2 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 1:252,613,875...252,672,459
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
multiple interactions |
ISO EXP |
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCC6 mRNA [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABCC6 mRNA |
CTD |
PMID:17917374 PMID:18544905 |
|
NCBI chr 1:105,583,681...105,637,895
|
|
G |
Abcc9 |
ATP binding cassette subfamily C member 9 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCC9 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr 4:177,262,848...177,386,837
|
|
G |
Abcd1 |
ATP binding cassette subfamily D member 1 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCD1 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr X:156,579,669...156,601,448
|
|
G |
Abcf2 |
ATP binding cassette subfamily F member 2 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCF2 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr 4:11,485,865...11,500,067
|
|
G |
Abhd1 |
abhydrolase domain containing 1 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABHD1 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr 6:31,142,476...31,147,464
|
|
G |
Acer3 |
alkaline ceramidase 3 |
increases expression |
ISO |
kojic acid results in increased expression of ACER3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:161,915,397...162,017,802
|
|
G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
decreases expression |
ISO |
kojic acid results in decreased expression of ACMSD mRNA |
CTD |
PMID:16595896 |
|
NCBI chr13:41,752,894...41,798,427
|
|
G |
Acvrl1 |
activin A receptor like type 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of ACVRL1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:134,117,917...134,135,306
|
|
G |
Adrb3 |
adrenoceptor beta 3 |
decreases expression |
ISO |
kojic acid results in decreased expression of ADRB3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr16:71,544,603...71,547,410
|
|
G |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
increases expression |
ISO |
kojic acid results in increased expression of AGAP3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 4:11,567,191...11,617,610
|
|
G |
Agbl4 |
AGBL carboxypeptidase 4 |
decreases expression |
ISO |
kojic acid results in decreased expression of AGBL4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:130,483,551...131,762,906
|
|
G |
Ahnak |
AHNAK nucleoprotein |
decreases expression |
ISO |
kojic acid results in decreased expression of AHNAK mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:215,311,289...215,400,010
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of AKT1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 6:137,534,810...137,555,131
|
|
G |
Alpi |
alkaline phosphatase, intestinal |
decreases expression |
ISO |
kojic acid results in decreased expression of ALPI mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 9:95,221,314...95,224,780
|
|
G |
Amtn |
amelotin |
decreases expression |
ISO |
kojic acid results in decreased expression of AMTN mRNA |
CTD |
PMID:16595896 |
|
NCBI chr14:19,932,664...19,945,223
|
|
G |
Anxa1 |
annexin A1 |
decreases expression |
ISO |
kojic acid results in decreased expression of ANXA1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:227,287,713...227,306,739
|
|
G |
Anxa5 |
annexin A5 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ANXA5 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr 2:121,242,133...121,272,935
|
|
G |
Ap1s1 |
adaptor related protein complex 1 subunit sigma 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of AP1S1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr12:25,261,958...25,272,483
|
|
G |
Apobec1 |
apolipoprotein B mRNA editing enzyme catalytic subunit 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of APOBEC1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 4:157,472,879...157,500,496
|
|
G |
App |
amyloid beta precursor protein |
increases expression |
ISO |
kojic acid results in increased expression of APP mRNA |
CTD |
PMID:16595896 |
|
NCBI chr11:37,506,207...37,724,351
|
|
G |
Aptx |
aprataxin |
decreases expression |
ISO |
kojic acid results in decreased expression of APTX mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:60,593,338...60,618,946
|
|
G |
Aqp1 |
aquaporin 1 |
increases expression |
ISO |
kojic acid results in increased expression of AQP1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 4:85,812,784...85,824,964
|
|
G |
Arfip2 |
ARF interacting protein 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of ARFIP2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:169,387,484...169,392,290
|
|
G |
Arhgef16 |
Rho guanine nucleotide exchange factor 16 |
decreases expression |
ISO |
kojic acid results in decreased expression of ARHGEF16 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:170,126,573...170,148,624
|
|
G |
Arl6ip5 |
ARF like GTPase 6 interacting protein 5 |
increases expression |
ISO |
kojic acid results in increased expression of ARL6IP5 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 4:131,365,320...131,395,311
|
|
G |
Asnsd1 |
asparagine synthetase domain containing 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of ASNSD1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 9:55,618,799...55,631,064
|
|
G |
Atf6b |
activating transcription factor 6 beta |
decreases expression |
ISO |
kojic acid results in decreased expression of ATF6B mRNA |
CTD |
PMID:16595896 |
|
NCBI chr20:4,095,534...4,103,534
|
|
G |
Atm |
ATM serine/threonine kinase |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ATM mRNA |
CTD |
PMID:17917374 |
|
NCBI chr 8:62,724,939...62,829,040
|
|
G |
B4galnt4 |
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
decreases expression |
ISO |
kojic acid results in decreased expression of B4GALNT4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:205,600,989...205,611,889
|
|
G |
Bag5 |
BAG cochaperone 5 |
decreases expression |
ISO |
kojic acid results in decreased expression of BAG5 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 6:136,589,623...136,593,278
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
increases expression |
ISO |
kojic acid results in increased expression of BCL2A1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:98,596,806...98,604,890
|
|
G |
Bcl2l2 |
Bcl2-like 2 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of BCL2L2 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr15:32,326,686...32,337,834
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of BIRC2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:13,253,697...13,273,672
|
|
G |
Bmp5 |
bone morphogenetic protein 5 |
decreases expression |
ISO |
kojic acid results in decreased expression of BMP5 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:85,397,629...85,520,374
|
|
G |
Brsk1 |
BR serine/threonine kinase 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of BRSK1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:78,162,944...78,193,598
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of BST2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr16:18,250,593...18,254,967
|
|
G |
C2h1orf54 |
similar to human chromosome 1 open reading frame 54 |
increases expression |
ISO |
kojic acid results in increased expression of C1ORF54 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:186,113,922...186,124,637
|
|
G |
C5h1orf87 |
similar to human chromosome 1 open reading frame 87 |
decreases expression |
ISO |
kojic acid results in decreased expression of C1ORF87 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:116,458,224...116,527,281
|
|
G |
Cab39l |
calcium binding protein 39-like |
increases expression |
ISO |
kojic acid results in increased expression of CAB39L mRNA |
CTD |
PMID:16595896 |
|
NCBI chr15:37,782,778...37,885,191
|
|
G |
Calr |
calreticulin |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CALR mRNA |
CTD |
PMID:18544905 |
|
NCBI chr19:40,213,367...40,218,262
|
|
G |
Car13 |
carbonic anhydrase 13 |
increases expression |
ISO |
kojic acid results in increased expression of CAR13 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 2:88,649,643...88,680,763
|
|
G |
Car14 |
carbonic anhydrase 14 |
increases expression |
ISO |
kojic acid results in increased expression of CA14 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:186,131,196...186,138,164
|
|
G |
Casp4 |
caspase 4 |
multiple interactions |
EXP |
[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CASP4 mRNA; Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CASP4 mRNA] |
CTD |
PMID:18544905 |
|
NCBI chr 8:10,883,817...10,919,978
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 9:67,747,109...67,806,699
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CAT mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 3:110,297,340...110,329,526
|
|
G |
Ccar1 |
cell division cycle and apoptosis regulator 1 |
increases expression |
ISO |
kojic acid results in increased expression of CCAR1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr20:31,228,624...31,271,233
|
|
G |
Ccdc50 |
coiled-coil domain containing 50 |
increases expression |
ISO |
kojic acid results in increased expression of CCDC50 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr11:86,837,624...86,900,164
|
|
G |
Ccl21 |
C-C motif chemokine ligand 21 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCL21A mRNA |
CTD |
PMID:17917374 |
|
NCBI chr 5:61,776,411...61,777,515
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCL3 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr10:68,948,889...68,950,439
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO |
kojic acid results in increased expression of CCNB1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 2:33,646,252...33,655,225
|
|
G |
Ccnc |
cyclin C |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCNC mRNA |
CTD |
PMID:17917374 |
|
NCBI chr 5:40,063,589...40,081,731
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
EXP ISO |
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CCND1 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCND1 mRNA |
CTD |
PMID:17917374 PMID:18544905 |
|
NCBI chr 1:209,518,288...209,527,986
|
|
G |
Ccng1 |
cyclin G1 |
multiple interactions |
EXP ISO |
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of CCNG1 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCNG1 mRNA |
CTD |
PMID:17917374 PMID:18544905 |
|
NCBI chr10:25,678,503...25,684,876
|
|
G |
Ccpg1 |
cell cycle progression 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of CCPG1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:82,600,677...82,633,082
|
|
G |
Ccr4 |
C-C motif chemokine receptor 4 |
decreases expression |
ISO |
kojic acid results in decreased expression of CCR4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:123,054,505...123,060,244
|
|
G |
Cd22 |
CD22 molecule |
decreases expression |
ISO |
kojic acid results in decreased expression of CD22 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:95,243,785...95,270,430
|
|
G |
Cd274 |
CD274 molecule |
increases expression |
ISO |
kojic acid results in increased expression of CD274 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:236,526,215...236,549,956
|
|
G |
Cd3g |
CD3 gamma subunit of T-cell receptor complex |
decreases expression |
ISO |
kojic acid results in decreased expression of CD3G mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:54,177,572...54,184,087
|
|
G |
Cdin1 |
CDAN1 interacting nuclease 1 |
increases expression |
ISO |
kojic acid results in increased expression of CDIN1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:122,895,754...123,101,099
|
|
G |
Cdk10 |
cyclin-dependent kinase 10 |
decreases expression |
ISO |
kojic acid results in decreased expression of CDK10 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr19:68,168,040...68,184,923
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CDKN1A mRNA [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CDKN1A mRNA |
CTD |
PMID:17917374 PMID:18544905 |
|
NCBI chr20:7,150,820...7,161,373
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 4:169,491,273...169,496,500
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of CEACAM1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:90,171,401...90,187,810
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
increases expression |
ISO |
kojic acid results in increased expression of CEBPD mRNA |
CTD |
PMID:16595896 |
|
NCBI chr11:98,268,856...98,269,994
|
|
G |
Cenpq |
centromere protein Q |
decreases expression |
ISO |
kojic acid results in decreased expression of CENPQ mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 9:27,454,339...27,469,371
|
|
G |
Cep192 |
centrosomal protein 192 |
increases expression |
ISO |
kojic acid results in increased expression of CEP192 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr18:63,643,816...63,728,264
|
|
G |
Cep72 |
centrosomal protein 72 |
increases expression |
ISO |
kojic acid results in increased expression of CEP72 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:31,053,884...31,083,863
|
|
G |
Ces1d |
carboxylesterase 1D |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of CES1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr19:30,046,494...30,085,039
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions |
EXP |
[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CHEK2 mRNA; Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CHEK2 mRNA] |
CTD |
PMID:18544905 |
|
NCBI chr12:51,448,838...51,481,159
|
|
G |
Chst4 |
carbohydrate sulfotransferase 4 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CHST4 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr19:54,900,914...54,911,735
|
|
G |
Cibar1 |
CBY1 interacting BAR domain containing 1 |
increases expression |
ISO |
kojic acid results in increased expression of CIBAR1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:30,411,325...30,429,770
|
|
G |
Cldn3 |
claudin 3 |
decreases expression |
ISO |
kojic acid results in decreased expression of CLDN3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr12:27,345,075...27,346,547
|
|
G |
Cldnd2 |
claudin domain containing 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of CLDND2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:102,985,122...102,988,010
|
|
G |
Clec4b2 |
C-type lectin domain family 4, member B2 |
decreases expression |
ISO |
kojic acid results in decreased expression of CLEC4C mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 4:158,148,434...158,171,933
|
|
G |
Clmp |
CXADR-like membrane protein |
decreases expression |
ISO |
kojic acid results in decreased expression of CLMP mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:49,957,639...50,065,959
|
|
G |
Clu |
clusterin |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CLU mRNA |
CTD |
PMID:18544905 |
|
NCBI chr15:44,336,619...44,375,861
|
|
G |
Cnih1 |
cornichon family member 1 |
increases expression |
ISO |
kojic acid results in increased expression of CNIH1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr15:22,517,755...22,529,651
|
|
G |
Cnksr2 |
connector enhancer of kinase suppressor of Ras 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of CNKSR2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr X:40,722,843...40,971,730
|
|
G |
Col17a1 |
collagen type XVII alpha 1 chain |
decreases expression |
ISO |
kojic acid results in decreased expression of COL17A1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:256,472,648...256,518,857
|
|
G |
Col24a1 |
collagen type XXIV alpha 1 chain |
decreases expression |
ISO |
kojic acid results in decreased expression of COL24A1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:236,872,583...237,129,768
|
|
G |
Colq |
collagen like tail subunit of asymmetric acetylcholinesterase |
increases expression |
ISO |
kojic acid results in increased expression of COLQ mRNA |
CTD |
PMID:16595896 |
|
NCBI chr16:6,738,251...6,830,492
|
|
G |
Comt |
catechol-O-methyltransferase |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of COMT mRNA |
CTD |
PMID:18544905 |
|
NCBI chr11:96,072,371...96,091,956
|
|
G |
Cops2 |
COP9 signalosome subunit 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of COPS2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:133,537,729...133,563,493
|
|
G |
Coq10a |
coenzyme Q10A |
increases expression |
ISO |
kojic acid results in increased expression of COQ10A mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:1,376,591...1,387,694
|
|
G |
Coq8a |
coenzyme Q8A |
increases expression |
ISO |
kojic acid results in increased expression of COQ8A mRNA |
CTD |
PMID:16595896 |
|
NCBI chr13:94,436,680...94,465,535
|
|
G |
Cpb1 |
carboxypeptidase B1 |
decreases expression |
ISO |
kojic acid results in decreased expression of CPB1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:104,684,275...104,744,824
|
|
G |
Cpe |
carboxypeptidase E |
increases expression |
ISO |
kojic acid results in increased expression of CPE mRNA |
CTD |
PMID:16595896 |
|
NCBI chr16:29,796,707...29,908,647
|
|
G |
Cpne5 |
copine 5 |
increases expression |
ISO |
kojic acid results in increased expression of CPNE5 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr20:7,208,389...7,290,959
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
decreases phosphorylation |
ISO |
kojic acid results in decreased phosphorylation of CREB1 protein |
CTD |
PMID:27586645 |
|
NCBI chr 9:73,397,333...73,466,339
|
|
G |
Cse1l |
chromosome segregation 1 like |
decreases expression |
ISO |
kojic acid results in decreased expression of CSE1L mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:176,060,183...176,097,909
|
|
G |
Ctnnal1 |
catenin alpha-like 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of CTNNAL1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:76,309,546...76,375,869
|
|
G |
Ctsz |
cathepsin Z |
increases expression |
ISO |
kojic acid results in increased expression of CTSZ mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:183,643,077...183,653,847
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYB5R3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYB5R3 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 7:116,186,729...116,204,290
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
increases expression |
ISO |
kojic acid results in increased expression of CYP26B1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 4:118,599,356...118,616,176
|
|
G |
Cyp2b15 |
cytochrome P450, family 2, subfamily b, polypeptide 15 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2B15 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP2B15 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 1:91,221,865...91,234,169
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B10 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2C mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 1:246,175,216...246,211,445
|
|
G |
Cyp2c13 |
cytochrome P450, family 2, subfamily c, polypeptide 13 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2C13 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 1:248,706,787...248,787,239
|
|
G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2C7 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 1:247,966,295...248,022,393
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2D22 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP2D22 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 7:115,762,662...115,771,832
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 1:205,269,967...205,280,365
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2F2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP2F2 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 1:91,543,768...91,557,553
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4A22 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP4A22 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 5:134,360,096...134,374,233
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
multiple interactions |
ISO EXP |
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CYP4B1 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4B1 mRNA |
CTD |
PMID:17917374 PMID:18544905 |
|
NCBI chr 5:134,375,807...134,413,635
|
|
G |
Cyp4f4 |
cytochrome P450, family 4, subfamily f, polypeptide 4 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4F2 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 7:12,367,711...12,384,010
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP7A1 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr 5:24,174,505...24,184,202
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP8B1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 8:130,455,622...130,457,592
|
|
G |
Cyth3 |
cytohesin 3 |
increases expression |
ISO |
kojic acid results in increased expression of CYTH3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr12:15,953,781...16,076,584
|
|
G |
Cytip |
cytohesin 1 interacting protein |
increases expression |
ISO |
kojic acid results in increased expression of CYTIP mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:63,106,895...63,183,769
|
|
G |
Dagla |
diacylglycerol lipase, alpha |
increases expression |
ISO |
kojic acid results in increased expression of DAGLA mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:216,315,515...216,372,219
|
|
G |
Dazap2 |
DAZ associated protein 2 |
increases expression |
ISO |
kojic acid results in increased expression of DAZAP2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:133,593,503...133,599,044
|
|
G |
Dcaf13 |
DDB1 and CUL4 associated factor 13 |
decreases expression |
ISO |
kojic acid results in decreased expression of DCAF13 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:72,045,828...72,081,039
|
|
G |
Dct |
dopachrome tautomerase |
decreases expression |
ISO |
kojic acid results in decreased expression of DCT protein |
CTD |
PMID:27586645 |
|
NCBI chr15:101,469,159...101,508,029
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DDIT3 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 7:65,001,695...65,006,517
|
|
G |
Dek |
DEK proto-oncogene |
decreases expression |
ISO |
kojic acid results in decreased expression of DEK mRNA |
CTD |
PMID:16595896 |
|
NCBI chr17:17,786,989...17,809,096
|
|
G |
Dlgap4 |
DLG associated protein 4 |
increases expression |
ISO |
kojic acid results in increased expression of DLGAP4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:165,584,271...165,731,868
|
|
G |
Dlx1 |
distal-less homeobox 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of DLX1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:76,763,864...76,768,454
|
|
G |
Dmxl1 |
Dmx-like 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of DMXL1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr18:45,179,505...45,349,999
|
|
G |
Dnaja1 |
DnaJ heat shock protein family (Hsp40) member A1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DNAJA1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 5:60,638,404...60,649,315
|
|
G |
Dnaja2 |
DnaJ heat shock protein family (Hsp40) member A2 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DNAJA2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of DNAJA2 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr19:37,671,019...37,689,163
|
|
G |
Dnttip2 |
deoxynucleotidyltransferase, terminal, interacting protein 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of DNTTIP2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:213,058,975...213,071,020
|
|
G |
Dock4 |
dedicator of cytokinesis 4 |
increases expression |
ISO |
kojic acid results in increased expression of DOCK4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 6:63,240,050...63,629,772
|
|
G |
Dok4 |
docking protein 4 |
decreases expression |
ISO |
kojic acid results in decreased expression of DOK4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr19:10,152,511...10,163,182
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of DPYD mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 2:209,293,902...210,159,777
|
|
G |
Dspp |
dentin sialophosphoprotein |
decreases expression |
ISO |
kojic acid results in decreased expression of DSPP mRNA |
CTD |
PMID:16595896 |
|
NCBI chr14:5,870,232...5,876,339
|
|
G |
Dstn |
destrin, actin depolymerizing factor |
increases expression |
ISO |
kojic acid results in increased expression of DSTN mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:151,737,711...151,764,752
|
|
G |
Dynlt3 |
dynein light chain Tctex-type 3 |
decreases expression |
ISO |
kojic acid results in decreased expression of DYNLT3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr X:16,000,425...16,009,632
|
|
G |
E2f3 |
E2F transcription factor 3 |
increases expression |
ISO |
kojic acid results in increased expression of E2F3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr17:34,810,355...34,887,725
|
|
G |
E2f8 |
E2F transcription factor 8 |
increases expression |
ISO |
kojic acid results in increased expression of E2F8 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:107,701,985...107,720,538
|
|
G |
Efna3 |
ephrin A3 |
decreases expression |
ISO |
kojic acid results in decreased expression of EFNA3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:177,026,928...177,035,838
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of EGR1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr18:26,737,078...26,740,877
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
decreases expression |
ISO |
kojic acid results in decreased expression of EIF4E mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:229,736,309...229,772,628
|
|
G |
Eif5a2 |
eukaryotic translation initiation factor 5A2 |
increases expression |
ISO |
kojic acid results in increased expression of EIF5A2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:113,656,748...113,674,598
|
|
G |
Elane |
elastase, neutrophil expressed |
decreases expression |
ISO |
kojic acid results in decreased expression of ELANE mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:10,467,877...10,469,725
|
|
G |
Ep300 |
E1A binding protein p300 |
increases expression |
ISO |
kojic acid results in increased expression of EP300 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:114,987,857...115,058,652
|
|
G |
Epha10 |
EPH receptor A10 |
decreases expression |
ISO |
kojic acid results in decreased expression of EPHA10 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:142,424,260...142,460,305
|
|
G |
Epha4 |
Eph receptor A4 |
increases expression |
ISO |
kojic acid results in increased expression of EPHA4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 9:86,263,982...86,406,744
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of EPHX1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of EPHX1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr13:95,246,079...95,275,852
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of EPHX2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of EPHX2 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr15:44,465,447...44,503,157
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC2 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr 1:88,161,342...88,175,102
|
|
G |
Ercc3 |
ERCC excision repair 3, TFIIH core complex helicase subunit |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of ERCC3 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr18:24,157,831...24,188,543
|
|
G |
Ercc4 |
ERCC excision repair 4, endonuclease catalytic subunit |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC4 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr10:2,926,085...2,958,176
|
|
G |
Ercc5 |
ERCC excision repair 5, endonuclease |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC5 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr 9:53,801,471...53,846,611
|
|
G |
Esam |
endothelial cell adhesion molecule |
increases expression |
ISO |
kojic acid results in increased expression of ESAM mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:45,426,985...45,437,976
|
|
G |
Esrp1 |
epithelial splicing regulatory protein 1 |
increases expression |
ISO |
kojic acid results in increased expression of ESRP1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:29,224,831...29,279,381
|
|
G |
Exd1 |
exonuclease 3'-5' domain containing 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of EXD1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:126,961,800...126,989,738
|
|
G |
Exoc2 |
exocyst complex component 2 |
increases expression |
ISO |
kojic acid results in increased expression of EXOC2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr17:33,714,949...33,906,901
|
|
G |
F10 |
coagulation factor X |
increases expression |
ISO |
kojic acid results in increased expression of F10 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr16:83,170,973...83,190,280
|
|
G |
Fam241a |
family with sequence similarity 241 member A |
increases expression |
ISO |
kojic acid results in increased expression of FAM241A mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:219,019,025...219,049,648
|
|
G |
Fbn2 |
fibrillin 2 |
increases expression |
ISO |
kojic acid results in increased expression of FBN2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr18:53,696,197...53,901,992
|
|
G |
Fbxo16 |
F-box protein 16 |
increases expression |
ISO |
kojic acid results in increased expression of FBXO16 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr15:43,667,207...43,717,096
|
|
G |
Ferry3 |
FERRY endosomal RAB5 effector complex subunit 3 |
decreases expression |
ISO |
kojic acid results in decreased expression of FERRY3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 4:161,458,942...161,494,213
|
|
G |
Fgf12 |
fibroblast growth factor 12 |
increases expression |
ISO |
kojic acid results in increased expression of FGF12 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr11:85,501,947...86,069,543
|
|
G |
Fgf5 |
fibroblast growth factor 5 |
decreases expression |
ISO |
kojic acid results in decreased expression of FGF5 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr14:11,627,906...11,650,243
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
decreases expression |
ISO |
kojic acid results in decreased expression of FGFR3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr14:81,211,800...81,227,215
|
|
G |
Fibcd1 |
fibrinogen C domain containing 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of FIBCD1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:35,490,459...35,524,142
|
|
G |
Fkbp10 |
FKBP prolyl isomerase 10 |
increases expression |
ISO |
kojic acid results in increased expression of FKBP10 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:85,845,801...85,858,361
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of FMO1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of FMO1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr13:77,715,405...77,747,666
|
|
G |
Fpgt |
fucose-1-phosphate guanylyltransferase |
decreases expression |
ISO |
kojic acid results in decreased expression of FPGT mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:246,757,982...246,778,896
|
|
G |
Frmpd4 |
FERM and PDZ domain containing 4 |
decreases expression |
ISO |
kojic acid results in decreased expression of FRMPD4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr X:29,739,834...30,386,917
|
|
G |
Fsaf1 |
40S small subunit processome assembly factor 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of FSAF1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr19:69,705,313...69,719,894
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
kojic acid results in increased expression of FTH1 mRNA; kojic acid results in increased expression of FTH1 protein |
CTD |
PMID:23738040 |
|
NCBI chr 1:216,052,037...216,054,325
|
|
G |
Fzd8 |
frizzled class receptor 8 |
increases expression |
ISO |
kojic acid results in increased expression of FZD8 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr17:62,007,849...62,015,485
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GADD45B mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 7:9,428,689...9,430,991
|
|
G |
Galnt1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of GALNT1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr18:15,763,697...15,843,598
|
|
G |
Gfod1 |
Gfo/Idh/MocA-like oxidoreductase domain containing 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of GFOD1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr17:21,606,090...21,710,922
|
|
G |
Gle1 |
GLE1 RNA export mediator |
decreases expression |
ISO |
kojic acid results in decreased expression of GLE1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:33,607,160...33,638,879
|
|
G |
Gmpr |
guanosine monophosphate reductase |
decreases expression |
ISO |
kojic acid results in decreased expression of GMPR mRNA |
CTD |
PMID:16595896 |
|
NCBI chr17:19,357,992...19,395,807
|
|
G |
Gnb1 |
G protein subunit beta 1 |
increases expression |
ISO |
kojic acid results in increased expression of GNB1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:171,357,778...171,424,489
|
|
G |
Gpr146 |
G protein-coupled receptor 146 |
decreases expression |
ISO |
kojic acid results in decreased expression of GPR146 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr12:20,365,790...20,381,122
|
|
G |
Gpr26 |
G protein-coupled receptor 26 |
decreases expression |
ISO |
kojic acid results in decreased expression of GPR26 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:196,196,138...196,235,574
|
|
G |
Gpr32 |
G protein-coupled receptor 32 |
increases expression |
ISO |
kojic acid results in increased expression of GPR32 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:103,893,405...103,894,667
|
|
G |
Gpr61 |
G protein-coupled receptor 61 |
decreases expression |
ISO |
kojic acid results in decreased expression of GPR61 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:198,471,430...198,477,827
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GPX1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GPX1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 8:117,905,462...117,906,588
|
|
G |
Gsdma |
gasdermin A |
decreases expression |
ISO |
kojic acid results in decreased expression of GSDMA mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:84,110,590...84,135,804
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of GSR mRNA |
CTD |
PMID:17917374 |
|
NCBI chr16:65,185,574...65,228,742
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTA2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTA2 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 8:88,064,829...88,077,168
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTA3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTA3 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 9:31,154,989...31,180,653
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTA4 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 8:87,947,247...87,964,490
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 2:198,338,005...198,346,007
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM2 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 2:198,312,179...198,316,962
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
multiple interactions |
ISO EXP |
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM3 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM3 mRNA |
CTD |
PMID:17917374 PMID:18544905 |
|
NCBI chr 2:198,219,769...198,222,732
|
|
G |
Gucy1a2 |
guanylate cyclase 1 soluble subunit alpha 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of GUCY1A2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:8,785,212...9,174,322
|
|
G |
H1f1 |
H1.1 linker histone, cluster member |
increases expression |
ISO |
kojic acid results in increased expression of H1-1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr17:41,762,278...41,794,876
|
|
G |
Hand1 |
heart and neural crest derivatives expressed 1 |
increases expression |
ISO |
kojic acid results in increased expression of HAND1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:42,507,117...42,509,684
|
|
G |
Harbi1 |
harbinger transposase derived 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of HARBI1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:98,137,087...98,145,992
|
|
G |
Hibch |
3-hydroxyisobutyryl-CoA hydrolase |
decreases expression |
ISO |
kojic acid results in decreased expression of HIBCH mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 9:56,082,082...56,161,796
|
|
G |
Hint3 |
histidine triad nucleotide binding protein 3 |
increases expression |
ISO |
kojic acid results in increased expression of HINT3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:28,854,860...28,864,723
|
|
G |
Hip1 |
huntingtin interacting protein 1 |
increases expression |
ISO |
kojic acid results in increased expression of HIP1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr12:26,769,868...26,904,367
|
|
G |
Hist1h2al1 |
histone cluster 1 H2A family like 1 |
increases expression |
ISO |
kojic acid results in increased expression of H2AC6 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr17:47,403,701...47,404,167
|
|
G |
Hlf |
HLF transcription factor, PAR bZIP family member |
decreases expression |
ISO |
kojic acid results in decreased expression of HLF mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:75,651,320...75,708,979
|
|
G |
Hmmr |
hyaluronan-mediated motility receptor |
decreases expression |
ISO |
kojic acid results in decreased expression of HMMR mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:25,635,249...25,665,389
|
|
G |
Hmox2 |
heme oxygenase 2 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HMOX2 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr10:11,303,512...11,337,640
|
|
G |
Hnrnph2 |
heterogeneous nuclear ribonucleoprotein H2 |
increases expression |
ISO |
kojic acid results in increased expression of HNRNPH2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr X:102,074,175...102,080,115
|
|
G |
Hps3 |
HPS3, biogenesis of lysosomal organelles complex 2 subunit 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of HPS3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:104,413,618...104,455,091
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSP90AA1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 6:135,523,604...135,529,687
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSP90AB1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of HSP90AB1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 9:22,930,249...22,935,929
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPA1A mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of HSPA1A mRNA |
CTD |
PMID:18544905 |
|
NCBI chr20:3,875,411...3,877,866
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPA5 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 3:38,453,016...38,457,475
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPB1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr12:26,430,640...26,432,301
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPD1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 9:64,073,610...64,084,332
|
|
G |
Hspe1 |
heat shock protein family E (Hsp10) member 1 |
multiple interactions |
EXP ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPE1 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of HSPE1 mRNA |
CTD |
PMID:17917374 PMID:18544905 |
|
NCBI chr 9:64,084,327...64,087,415
|
|
G |
Hyou1 |
hypoxia up-regulated 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HYOU1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 8:53,602,882...53,614,998
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of IGF2R mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 1:50,526,878...50,615,265
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of IL1A mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 3:136,979,804...136,990,236
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of IL1B mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 3:137,030,200...137,036,581
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
increases expression |
ISO |
kojic acid results in increased expression of IL1RL1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 9:50,157,326...50,222,888
|
|
G |
Il22ra1 |
interleukin 22 receptor subunit alpha 1 |
increases expression |
ISO |
kojic acid results in increased expression of IL22RA1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:153,245,067...153,269,865
|
|
G |
Il6 |
interleukin 6 |
decreases expression |
ISO |
kojic acid results in decreased expression of IL6 protein |
CTD |
PMID:12727023 |
|
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
decreases expression |
ISO |
kojic acid results in decreased expression of IL6ST mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:45,798,872...45,839,501
|
|
G |
Incenp |
inner centromere protein |
increases expression |
ISO |
kojic acid results in increased expression of INCENP mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:215,945,558...216,017,247
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
kojic acid results in increased expression of JUN mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 5:115,009,900...115,012,993
|
|
G |
Kars1 |
lysyl-tRNA synthetase 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of KARS1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr19:56,867,096...56,886,151
|
|
G |
Kcnab3 |
potassium voltage-gated channel subfamily A regulatory beta subunit 3 |
decreases expression |
ISO |
kojic acid results in decreased expression of KCNAB3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:54,546,638...54,555,209
|
|
G |
Kctd17 |
potassium channel tetramerization domain containing 17 |
decreases expression |
ISO |
kojic acid results in decreased expression of KCTD17 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:111,859,556...111,891,869
|
|
G |
Kdm4d |
lysine demethylase 4D |
increases expression |
ISO |
kojic acid results in increased expression of KDM4D mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:19,561,253...19,586,412
|
|
G |
Klf5 |
KLF transcription factor 5 |
increases expression |
ISO |
kojic acid results in increased expression of KLF5 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr15:82,472,081...82,487,267
|
|
G |
Klhl13 |
kelch-like family member 13 |
increases expression |
ISO |
kojic acid results in increased expression of KLHL13 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr X:118,747,298...118,912,279
|
|
G |
Klkb1 |
kallikrein B1 |
decreases expression |
ISO |
kojic acid results in decreased expression of KLKB1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr16:53,690,180...53,714,570
|
|
G |
Krt7 |
keratin 7 |
increases expression |
ISO |
kojic acid results in increased expression of KRT7 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:134,407,626...134,423,787
|
|
G |
Ktn1 |
kinectin 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of KTN1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr15:23,392,570...23,485,061
|
|
G |
Larp7 |
La ribonucleoprotein 7, transcriptional regulator |
decreases expression |
ISO |
kojic acid results in decreased expression of LARP7 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:218,672,145...218,687,332
|
|
G |
Lilrb3 |
leukocyte immunoglobulin like receptor B3 |
decreases expression |
ISO |
kojic acid results in decreased expression of LILRB5 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:79,001,483...79,011,054
|
|
G |
Lrp6 |
LDL receptor related protein 6 |
decreases expression |
ISO |
kojic acid results in decreased expression of LRP6 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 4:168,997,937...169,131,716
|
|
G |
Lrrc4 |
leucine rich repeat containing 4 |
decreases expression |
ISO |
kojic acid results in decreased expression of LRRC4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 4:58,398,942...58,402,538
|
|
G |
Lrrc9 |
leucine rich repeat containing 9 |
increases expression |
ISO |
kojic acid results in increased expression of LRRC9 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 6:96,746,972...96,831,840
|
|
G |
Maea |
macrophage erythroblast attacher, E3 ubiquitin ligase |
increases expression |
ISO |
kojic acid results in increased expression of MAEA mRNA |
CTD |
PMID:16595896 |
|
NCBI chr14:81,581,784...81,615,246
|
|
G |
Mafk |
MAF bZIP transcription factor K |
decreases expression |
ISO |
kojic acid results in decreased expression of MAFK mRNA |
CTD |
PMID:16595896 |
|
NCBI chr12:19,948,473...19,970,351
|
|
G |
Magec2 |
MAGE family member C2 |
increases expression |
ISO |
kojic acid results in increased expression of MAGEC2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr X:145,646,856...145,651,730
|
|
G |
Maoa |
monoamine oxidase A |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MAOA mRNA |
CTD |
PMID:18544905 |
|
NCBI chr X:8,615,239...8,681,372
|
|
G |
Maob |
monoamine oxidase B |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MAOB mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of MAOB mRNA |
CTD |
PMID:18544905 |
|
NCBI chr X:8,490,405...8,594,065
|
|
G |
Map7d2 |
MAP7 domain containing 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of MAP7D2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr X:39,181,091...39,296,814
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation |
ISO |
kojic acid results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:27586645 |
|
NCBI chr11:97,462,025...97,529,193
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
ISO |
kojic acid results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:27586645 |
|
NCBI chr 1:190,797,189...190,803,411
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
decreases expression |
ISO |
kojic acid results in decreased expression of MAPK8 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr16:8,645,171...8,728,225
|
|
G |
Mbnl1 |
muscleblind-like splicing regulator 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of MBNL1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:146,789,570...146,964,136
|
|
G |
Mc1r |
melanocortin 1 receptor |
decreases expression increases expression |
ISO |
kojic acid results in decreased expression of MC1R protein kojic acid results in increased expression of MC1R protein |
CTD |
PMID:23738040 PMID:27586645 |
|
NCBI chr19:68,360,950...68,363,877
|
|
G |
Mdfi |
MyoD family inhibitor |
decreases expression |
ISO |
kojic acid results in decreased expression of MDFI mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 9:20,654,359...20,672,768
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MDM2 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 7:55,176,558...55,201,757
|
|
G |
Me3 |
malic enzyme 3 |
decreases expression |
ISO |
kojic acid results in decreased expression of ME3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:152,946,595...153,148,026
|
|
G |
Med14 |
mediator complex subunit 14 |
increases expression |
ISO |
kojic acid results in increased expression of MED14 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr X:12,709,406...12,800,642
|
|
G |
Mex3b |
mex-3 RNA binding family member B |
increases expression |
ISO |
kojic acid results in increased expression of MEX3B mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:146,264,319...146,268,554
|
|
G |
Mfap4 |
microfibril associated protein 4 |
decreases expression |
ISO |
kojic acid results in decreased expression of MFAP4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:46,666,552...46,669,613
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
multiple interactions |
EXP |
[kojic acid co-treated with Diethylnitrosamine] results in increased expression of MGMT mRNA; Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of MGMT mRNA] |
CTD |
PMID:18544905 |
|
NCBI chr 1:201,140,832...201,367,481
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MGST1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of MGST1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 4:172,760,930...172,776,157
|
|
G |
Midn |
midnolin |
decreases expression |
ISO |
kojic acid results in decreased expression of MIDN mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:10,198,761...10,210,563
|
|
G |
Mif |
macrophage migration inhibitory factor |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MIF mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of MIF mRNA |
CTD |
PMID:18544905 |
|
NCBI chr20:12,767,138...12,791,222
|
|
G |
Mnd1 |
meiotic nuclear divisions 1 |
increases expression |
ISO |
kojic acid results in increased expression of GAJ mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:171,731,523...171,794,124
|
|
G |
Mrpl30 |
mitochondrial ribosomal protein L30 |
decreases expression |
ISO |
kojic acid results in decreased expression of MRPL30 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 9:47,621,226...47,631,986
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
increases expression |
ISO |
kojic acid results in increased expression of COX1 mRNA; kojic acid results in increased expression of COX1 protein |
CTD |
PMID:23738040 |
|
|
|
G |
Mtrex |
Mtr4 exosome RNA helicase |
decreases expression |
ISO |
kojic acid results in decreased expression of MTREX mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:46,233,528...46,293,827
|
|
G |
Mvp |
major vault protein |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MVP mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 1:191,025,259...191,052,866
|
|
G |
Naa25 |
N(alpha)-acetyltransferase 25, NatB auxiliary subunit |
increases expression |
ISO |
kojic acid results in increased expression of NAA25 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr12:40,758,909...40,811,192
|
|
G |
Ncald |
neurocalcin delta |
decreases expression |
ISO |
kojic acid results in decreased expression of NCALD mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:70,417,683...70,849,763
|
|
G |
Ndufa1 |
NADH:ubiquinone oxidoreductase subunit A1 |
increases expression |
ISO |
kojic acid results in increased expression of NDUFA1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr X:121,289,904...121,293,555
|
|
G |
Nectin4 |
nectin cell adhesion molecule 4 |
increases expression |
ISO |
kojic acid results in increased expression of NECTIN4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr13:86,335,027...86,354,152
|
|
G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
increases expression |
ISO |
kojic acid results in increased expression of NFIL3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr17:12,432,376...12,447,605
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of NFKBIA mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of NFKBIA mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 6:78,593,844...78,597,307
|
|
G |
Nfkbie |
NFKB inhibitor epsilon |
increases expression |
ISO |
kojic acid results in increased expression of NFKBIE mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 9:22,941,037...22,947,872
|
|
G |
Nkx6-1 |
NK6 homeobox 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of NKX6-1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr14:8,274,238...8,281,171
|
|
G |
Nlgn2 |
neuroligin 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of NLGN2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:55,042,175...55,056,578
|
|
G |
Noc3l |
NOC3-like DNA replication regulator |
decreases expression |
ISO |
kojic acid results in decreased expression of NOC3L mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:245,969,179...245,997,761
|
|
G |
Nol11 |
nucleolar protein 11 |
decreases expression |
ISO |
kojic acid results in decreased expression of NOL11 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:92,621,482...92,641,394
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of NR1I2 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr11:75,965,717...76,006,733
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of NR1I3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of NR1I3 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr13:86,165,327...86,170,362
|
|
G |
Odad2 |
outer dynein arm docking complex subunit 2 |
increases expression |
ISO |
kojic acid results in increased expression of ODAD2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr17:59,910,665...60,104,929
|
|
G |
Olfml1 |
olfactomedin-like 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of OLFML1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:170,889,912...170,914,300
|
|
G |
Or51b4 |
olfactory receptor family 51 subfamily B member 4 |
decreases expression |
ISO |
kojic acid results in decreased expression of OR51B4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:167,729,117...167,730,040
|
|
G |
Osbp2 |
oxysterol binding protein 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of OSBP2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr14:82,808,693...82,970,386
|
|
G |
Ostm1 |
osteoclastogenesis associated transmembrane protein 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of OSTM1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr20:47,653,696...47,769,248
|
|
G |
Otx1 |
orthodenticle homeobox 1 |
increases expression |
ISO |
kojic acid results in increased expression of OTX1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr14:100,283,406...100,290,421
|
|
G |
Pabir1 |
PP2A Aalpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1 |
increases expression |
ISO |
kojic acid results in increased expression of PABIR1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:231,541,411...231,542,717
|
|
G |
Pagr1 |
Paxip1-associated glutamate-rich protein 1 |
increases expression |
ISO |
kojic acid results in increased expression of PAGR1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:191,053,228...191,055,554
|
|
G |
Pah |
phenylalanine hydroxylase |
decreases expression |
ISO |
kojic acid results in decreased expression of PAH mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:23,793,096...23,885,631
|
|
G |
Parg |
poly (ADP-ribose) glycohydrolase |
increases expression |
ISO |
kojic acid results in increased expression of PARG mRNA |
CTD |
PMID:16595896 |
|
NCBI chr16:7,442,696...7,550,585
|
|
G |
Pbk |
PDZ binding kinase |
decreases expression |
ISO |
kojic acid results in decreased expression of PBK mRNA |
CTD |
PMID:16595896 |
|
NCBI chr15:44,198,506...44,209,572
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
ISO EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of PCNA protein [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of PCNA protein |
CTD |
PMID:17917374 PMID:18544905 |
|
NCBI chr 3:139,951,948...139,955,820
|
|
G |
Pcnx3 |
pecanex 3 |
decreases expression |
ISO |
kojic acid results in decreased expression of PCNX3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:212,380,657...212,402,967
|
|
G |
Pcsk4 |
proprotein convertase subtilisin/kexin type 4 |
decreases expression |
ISO |
kojic acid results in decreased expression of PCSK4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:10,032,040...10,040,263
|
|
G |
Pdcl |
phosducin like |
increases expression |
ISO |
kojic acid results in increased expression of PDCL mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:41,519,953...41,529,545
|
|
G |
Pdha1 |
pyruvate dehydrogenase E1 subunit alpha 1 |
increases expression |
ISO |
kojic acid results in increased expression of PDHA1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr X:38,509,158...38,522,986
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PDIA3 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 3:128,841,781...128,865,733
|
|
G |
Pdlim2 |
PDZ and LIM domain 2 |
increases expression |
ISO |
kojic acid results in increased expression of PDLIM2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr15:51,647,195...51,659,904
|
|
G |
Perm1 |
PPARGC1 and ESRR induced regulator, muscle 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of PERM1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:172,082,249...172,087,542
|
|
G |
Pex5l |
peroxisomal biogenesis factor 5-like |
decreases expression |
ISO |
kojic acid results in decreased expression of PEX5L mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:117,623,199...117,836,772
|
|
G |
Pgm2 |
phosphoglucomutase 2 |
increases expression |
ISO |
kojic acid results in increased expression of PGM2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr14:44,519,906...44,553,420
|
|
G |
Pigq |
phosphatidylinositol glycan anchor biosynthesis, class Q |
decreases expression |
ISO |
kojic acid results in decreased expression of PIGQ mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:15,447,080...15,463,088
|
|
G |
Pitpnb |
phosphatidylinositol transfer protein, beta |
increases expression |
ISO |
kojic acid results in increased expression of PITPNB mRNA |
CTD |
PMID:16595896 |
|
NCBI chr12:50,909,140...50,958,193
|
|
G |
Plagl1 |
PLAG1 like zinc finger 1 |
increases expression |
ISO |
kojic acid results in increased expression of PLAGL1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:9,297,066...9,337,394
|
|
G |
Poglut2 |
protein O-glucosyltransferase 2 |
increases expression |
ISO |
kojic acid results in increased expression of POGLUT2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 9:53,748,484...53,801,453
|
|
G |
Pon3 |
paraoxonase 3 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PON3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of PON3 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 4:34,323,546...34,350,244
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of POR mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of POR mRNA |
CTD |
PMID:18544905 |
|
NCBI chr12:26,587,674...26,655,612
|
|
G |
Pou2f3 |
POU class 2 homeobox 3 |
decreases expression |
ISO |
kojic acid results in decreased expression of POU2F3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:52,392,363...52,474,756
|
|
G |
Ppp4r1 |
protein phosphatase 4, regulatory subunit 1 |
increases expression |
ISO |
kojic acid results in increased expression of PPP4R1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 9:112,836,950...112,897,490
|
|
G |
Prdx1 |
peroxiredoxin 1 |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PRDX1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 5:135,383,906...135,399,504
|
|
G |
Prdx2 |
peroxiredoxin 2 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PRDX2 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr19:40,085,788...40,091,083
|
|
G |
Prg2 |
proteoglycan 2, pro eosinophil major basic protein |
decreases expression |
ISO |
kojic acid results in decreased expression of PRG2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:90,469,192...90,472,759
|
|
G |
Prickle3 |
prickle planar cell polarity protein 3 |
decreases expression |
ISO |
kojic acid results in decreased expression of PRICKLE3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr X:17,509,551...17,520,157
|
|
G |
Prim1 |
DNA primase subunit 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of PRIM1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:1,031,436...1,047,134
|
|
G |
Prmt2 |
protein arginine methyltransferase 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of PRMT2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr20:12,391,388...12,420,096
|
|
G |
Prpf40a |
pre-mRNA processing factor 40 homolog A |
decreases expression |
ISO |
kojic acid results in decreased expression of PRPF40A mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:58,036,779...58,098,996
|
|
G |
Prps2 |
phosphoribosyl pyrophosphate synthetase 2 |
increases expression |
ISO |
kojic acid results in increased expression of PRPS2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr X:30,592,845...30,630,127
|
|
G |
Prr18 |
proline rich 18 |
decreases expression |
ISO |
kojic acid results in decreased expression of PRR18 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:54,947,775...54,951,558
|
|
G |
Prrc2c |
proline-rich coiled-coil 2C |
increases expression |
ISO |
kojic acid results in increased expression of PRRC2C mRNA |
CTD |
PMID:16595896 |
|
NCBI chr13:77,537,226...77,606,926
|
|
G |
Prrx1 |
paired related homeobox 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of PRRX1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr13:78,136,783...78,205,379
|
|
G |
Psmc6 |
proteasome 26S subunit, ATPase 6 |
decreases expression |
ISO |
kojic acid results in decreased expression of PSMC6 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr15:21,022,314...21,043,785
|
|
G |
Psmd3 |
proteasome 26S subunit, non-ATPase 3 |
decreases expression |
ISO |
kojic acid results in decreased expression of PSMD3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:84,139,249...84,151,879
|
|
G |
Pus7l |
pseudouridine synthase 7 like |
decreases expression |
ISO |
kojic acid results in decreased expression of PUS7L mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:127,538,785...127,561,936
|
|
G |
Rab3gap1 |
RAB3 GTPase activating protein catalytic subunit 1 |
increases expression |
ISO |
kojic acid results in increased expression of RAB3GAP1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr13:41,908,179...41,981,611
|
|
G |
Rab6b |
RAB6B, member RAS oncogene family |
decreases expression |
ISO |
kojic acid results in decreased expression of RAB6B mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:112,574,223...112,642,911
|
|
G |
Rad1 |
RAD1 checkpoint DNA exonuclease |
increases expression |
ISO |
kojic acid results in increased expression of RAD1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:61,188,755...61,196,868
|
|
G |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RAD23A mRNA |
CTD |
PMID:18544905 |
|
NCBI chr19:40,219,235...40,225,543
|
|
G |
Rad50 |
RAD50 double strand break repair protein |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of RAD50 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr10:38,310,147...38,362,100
|
|
G |
Rara |
retinoic acid receptor, alpha |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RARA mRNA |
CTD |
PMID:18544905 |
|
NCBI chr10:84,379,780...84,424,371
|
|
G |
Rarb |
retinoic acid receptor, beta |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RARB mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of RARB mRNA |
CTD |
PMID:18544905 |
|
NCBI chr15:10,837,252...11,482,037
|
|
G |
Rasd1 |
ras related dexamethasone induced 1 |
increases expression |
ISO |
kojic acid results in increased expression of RASD1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:45,265,975...45,275,279
|
|
G |
Rasgef1b |
RasGEF domain family, member 1B |
decreases expression |
ISO |
kojic acid results in decreased expression of RASGEF1B mRNA |
CTD |
PMID:16595896 |
|
NCBI chr14:10,164,366...10,684,184
|
|
G |
Rassf3 |
Ras association domain family member 3 |
increases expression |
ISO |
kojic acid results in increased expression of RASSF3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:58,821,360...58,886,020
|
|
G |
Rb1cc1 |
RB1-inducible coiled-coil 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of RB1CC1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:17,948,522...18,012,434
|
|
G |
Rbm38 |
RNA binding motif protein 38 |
decreases expression |
ISO |
kojic acid results in decreased expression of RBM38 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:182,219,898...182,232,723
|
|
G |
Recql |
RecQ like helicase |
decreases expression |
ISO |
kojic acid results in decreased expression of RECQL mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 4:177,039,351...177,063,968
|
|
G |
Rims2 |
regulating synaptic membrane exocytosis 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of RIMS2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:72,133,004...72,644,059
|
|
G |
Rsbn1 |
round spermatid basic protein 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of RSBN1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:194,105,058...194,159,142
|
|
G |
Saa4 |
serum amyloid A4 |
decreases expression |
ISO |
kojic acid results in decreased expression of SAA4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:106,383,856...106,388,158
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
increases expression |
ISO |
kojic acid results in increased expression of SCARB1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr12:36,957,302...37,023,982
|
|
G |
Scn10a |
sodium voltage-gated channel alpha subunit 10 |
decreases expression |
ISO |
kojic acid results in decreased expression of SCN10A mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:128,228,424...128,340,749
|
|
G |
Scp2 |
sterol carrier protein 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of SCP2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:128,035,714...128,110,015
|
|
G |
Sdc4 |
syndecan 4 |
decreases expression |
ISO |
kojic acid results in decreased expression of SDC4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:173,574,239...173,592,923
|
|
G |
Sec24b |
SEC24 homolog B, COPII coat complex component |
increases expression |
ISO |
kojic acid results in increased expression of SEC24B mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:221,236,897...221,306,986
|
|
G |
Sec62 |
SEC62 homolog, preprotein translocation factor |
decreases expression |
ISO |
kojic acid results in decreased expression of SEC62 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:114,499,317...114,526,705
|
|
G |
Sectm1b |
secreted and transmembrane 1B |
decreases expression |
ISO |
kojic acid results in decreased expression of SECTM1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:106,822,397...106,832,105
|
|
G |
Septin7 |
septin 7 |
decreases expression |
ISO |
kojic acid results in decreased expression of SEPTIN7 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:31,995,597...32,059,069
|
|
G |
Serpina5 |
serpin family A member 5 |
decreases expression |
ISO |
kojic acid results in decreased expression of SERPINA5 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 6:128,774,006...128,793,187
|
|
G |
Shcbp1 |
SHC binding and spindle associated 1 |
increases expression |
ISO |
kojic acid results in increased expression of SHCBP1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr16:91,373,843...91,405,409
|
|
G |
Sin3b |
SIN3 transcription regulator family member B |
decreases expression |
ISO |
kojic acid results in decreased expression of SIN3B mRNA |
CTD |
PMID:16595896 |
|
NCBI chr16:17,157,352...17,194,051
|
|
G |
Slc17a2 |
solute carrier family 17, member 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of SLC17A2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr17:41,748,195...41,767,601
|
|
G |
Slc25a2 |
solute carrier family 25 member 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of SLC25A2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr18:29,704,182...29,707,563
|
|
G |
Slc38a4 |
solute carrier family 38, member 4 |
decreases expression |
ISO |
kojic acid results in decreased expression of SLC38A4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:130,022,039...130,082,169
|
|
G |
Smc6 |
structural maintenance of chromosomes 6 |
decreases expression |
ISO |
kojic acid results in decreased expression of SMC6 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 6:39,697,810...39,752,275
|
|
G |
Smim8 |
small integral membrane protein 8 |
decreases expression |
ISO |
kojic acid results in decreased expression of SMIM8 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:54,132,905...54,141,940
|
|
G |
Snx10 |
sorting nexin 10 |
decreases expression |
ISO |
kojic acid results in decreased expression of SNX10 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 4:81,943,262...82,007,667
|
|
G |
Soat2 |
sterol O-acyltransferase 2 |
increases expression |
ISO |
kojic acid results in increased expression of SOAT2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:135,160,424...135,173,521
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SOD1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr11:42,942,742...42,948,399
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SOD2 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 1:50,043,323...50,050,168
|
|
G |
Spata25 |
spermatogenesis associated 25 |
decreases expression |
ISO |
kojic acid results in decreased expression of SPATA25 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:173,981,863...173,983,818
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
increases expression |
ISO |
kojic acid results in increased expression of SPP1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr14:5,613,569...5,620,695
|
|
G |
Sptlc1 |
serine palmitoyltransferase, long chain base subunit 1 |
increases expression |
ISO |
kojic acid results in increased expression of SPTLC1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr17:12,029,189...12,068,234
|
|
G |
Srsf2 |
serine and arginine rich splicing factor 2 |
increases expression |
ISO |
kojic acid results in increased expression of SRSF2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:102,550,962...102,554,200
|
|
G |
Ssx1 |
SSX family member 1 |
increases expression |
ISO |
kojic acid results in increased expression of SSX1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr X:16,603,888...16,612,203
|
|
G |
St13 |
ST13, Hsp70 interacting protein |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of ST13 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 7:114,769,758...114,805,877
|
|
G |
St18 |
ST18 C2H2C-type zinc finger transcription factor |
decreases expression |
ISO |
kojic acid results in decreased expression of ST18 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:17,369,383...17,701,094
|
|
G |
Stard8 |
StAR-related lipid transfer domain containing 8 |
decreases expression |
ISO |
kojic acid results in decreased expression of STARD8 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr X:68,119,276...68,236,247
|
|
G |
Stx6 |
syntaxin 6 |
increases expression |
ISO |
kojic acid results in increased expression of STX6 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr13:69,882,647...69,928,895
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1A1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of SULT1A1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 1:190,702,592...190,706,112
|
|
G |
Sult1b1 |
sulfotransferase family 1B member 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1B1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of SULT1B1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr14:20,771,917...20,784,665
|
|
G |
Sult1c2a |
sulfotransferase family 1C member 2A |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1C2 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 9:7,075,873...7,103,316
|
|
G |
Sult1c3 |
sulfotransferase family 1C member 3 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1C1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 9:7,548,839...7,594,299
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
multiple interactions |
EXP ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1E1 mRNA [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of SULT1E1 mRNA |
CTD |
PMID:17917374 PMID:18544905 |
|
NCBI chr14:20,700,444...20,718,719
|
|
G |
Sult4a1 |
sulfotransferase family 4A, member 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT4A1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of SULT4A1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 7:117,096,064...117,120,714
|
|
G |
Suz12 |
SUZ12 polycomb repressive complex 2 subunit |
decreases expression |
ISO |
kojic acid results in decreased expression of SUZ12 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:65,464,948...65,510,846
|
|
G |
Swap70 |
switching B-cell complex subunit SWAP70 |
increases expression |
ISO |
kojic acid results in increased expression of SWAP70 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:173,702,338...173,763,540
|
|
G |
Syf2 |
SYF2 pre-mRNA-splicing factor |
decreases expression |
ISO |
kojic acid results in decreased expression of SYF2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:152,440,171...152,448,094
|
|
G |
Sympk |
symplekin scaffold protein |
decreases expression |
ISO |
kojic acid results in decreased expression of SYMPK mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:87,800,416...87,828,727
|
|
G |
Syncrip |
synaptotagmin binding, cytoplasmic RNA interacting protein |
increases expression |
ISO |
kojic acid results in increased expression of SYNCRIP mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:98,282,358...98,315,412
|
|
G |
Taf15 |
TATA-box binding protein associated factor 15 |
decreases expression |
ISO |
kojic acid results in decreased expression of TAF15 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:68,770,408...68,802,458
|
|
G |
Tal1 |
TAL bHLH transcription factor 1, erythroid differentiation factor |
decreases expression |
ISO |
kojic acid results in decreased expression of TAL1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:133,823,093...133,837,737
|
|
G |
Tbxas1 |
thromboxane A synthase 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TBXAS1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 4:68,631,841...68,803,959
|
|
G |
Tcf21 |
transcription factor 21 |
decreases expression |
ISO |
kojic acid results in decreased expression of TCF21 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:24,520,499...24,523,358
|
|
G |
Tent4b |
terminal nucleotidyltransferase 4B |
decreases expression |
ISO |
kojic acid results in decreased expression of TENT4B mRNA |
CTD |
PMID:16595896 |
|
NCBI chr19:34,984,244...35,042,423
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TGFB1 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 1:90,324,312...90,340,627
|
|
G |
Thrb |
thyroid hormone receptor beta |
decreases expression |
ISO |
kojic acid results in decreased expression of THRB mRNA |
CTD |
PMID:16595896 |
|
NCBI chr15:10,115,954...10,465,231
|
|
G |
Tie1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of TIE mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:137,285,408...137,305,047
|
|
G |
Tirap |
TIR domain containing adaptor protein |
decreases expression |
ISO |
kojic acid results in decreased expression of TIRAP mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:41,789,557...41,805,903
|
|
G |
Tmco5a |
transmembrane and coiled-coil domains 5A |
increases expression |
ISO |
kojic acid results in increased expression of TMCO5 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:124,187,005...124,200,308
|
|
G |
Tmem217 |
transmembrane protein 217 |
increases expression |
ISO |
kojic acid results in increased expression of TMEM217 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr20:7,594,223...7,620,628
|
|
G |
Tmem59l |
transmembrane protein 59-like |
decreases expression |
ISO |
kojic acid results in decreased expression of TMEM59L mRNA |
CTD |
PMID:16595896 |
|
NCBI chr16:18,975,217...18,979,354
|
|
G |
Tmx1 |
thioredoxin-related transmembrane protein 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of TMX1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 6:94,696,699...94,707,751
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TNF mRNA |
CTD |
PMID:18544905 |
|
NCBI chr20:3,626,685...3,629,303
|
|
G |
Tnfaip8l1 |
TNF alpha induced protein 8 like 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of TNFAIP8L1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 9:1,075,724...1,088,256
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TNFSF10 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 2:112,136,550...112,155,903
|
|
G |
Tor4a |
torsin family 4, member A |
decreases expression |
ISO |
kojic acid results in decreased expression of TOR4A mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:28,402,454...28,406,141
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
EXP ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TP53 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of TRP53 mRNA |
CTD |
PMID:17917374 PMID:18544905 |
|
NCBI chr10:54,798,871...54,810,300
|
|
G |
Tp53bp2 |
tumor protein p53 binding protein, 2 |
increases expression |
ISO |
kojic acid results in increased expression of TP53BP2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr13:96,620,429...96,677,090
|
|
G |
Tpcn1 |
two pore segment channel 1 |
increases expression |
ISO |
kojic acid results in increased expression of TPCN1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr12:41,633,399...41,690,200
|
|
G |
Tpst2 |
tyrosylprotein sulfotransferase 2 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TPST2 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr12:49,982,281...50,024,489
|
|
G |
Tradd |
TNFRSF1A-associated via death domain |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TRADD mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TRADD mRNA |
CTD |
PMID:18544905 |
|
NCBI chr19:50,046,057...50,048,158
|
|
G |
Tram1 |
translocation associated membrane protein 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of TRAM1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:10,425,710...10,450,669
|
|
G |
Tram2 |
translocation associated membrane protein 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of TRAM2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 9:30,915,624...30,995,162
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of TREM1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 9:20,259,227...20,276,879
|
|
G |
Trmt10c |
tRNA methyltransferase 10C, mitochondrial RNase P subunit |
decreases expression |
ISO |
kojic acid results in decreased expression of TRMT10C mRNA |
CTD |
PMID:16595896 |
|
NCBI chr11:58,053,455...58,058,533
|
|
G |
Tspan8 |
tetraspanin 8 |
increases expression |
ISO |
kojic acid results in increased expression of TSPAN8 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:53,331,019...53,365,402
|
|
G |
Ttc9 |
tetratricopeptide repeat domain 9 |
increases expression |
ISO |
kojic acid results in increased expression of TTC9 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 6:107,064,527...107,099,361
|
|
G |
Ttk |
Ttk protein kinase |
decreases expression |
ISO |
kojic acid results in decreased expression of TTK mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 8:93,632,678...93,672,664
|
|
G |
Tulp3 |
TUB like protein 3 |
decreases expression |
ISO |
kojic acid results in decreased expression of TULP3 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 4:163,276,583...163,318,297
|
|
G |
Twf1 |
twinfilin actin-binding protein 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of TWF1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:127,595,210...127,607,821
|
|
G |
Tyr |
tyrosinase |
decreases activity increases expression |
ISO |
kojic acid results in decreased activity of TYR protein kojic acid results in increased expression of TYR mRNA; kojic acid results in increased expression of TYR protein |
CTD |
PMID:23738040 PMID:27586645 |
|
NCBI chr 1:150,527,687...150,622,857
|
|
G |
Tyrp1 |
tyrosinase-related protein 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of TYRP1 protein |
CTD |
PMID:27586645 |
|
NCBI chr 5:100,327,111...100,345,657
|
|
G |
Ube2d2b |
ubiquitin-conjugating enzyme E2D 2B |
decreases expression |
ISO |
kojic acid results in decreased expression of UBE2D4 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr14:2,060,926...2,062,400
|
|
G |
Ube2e1 |
ubiquitin-conjugating enzyme E2E 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of UBE2E1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr15:9,870,528...9,924,194
|
|
G |
Ube2m |
ubiquitin-conjugating enzyme E2M |
decreases expression |
ISO |
kojic acid results in decreased expression of UBE2M mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:82,734,761...82,738,298
|
|
G |
Ubr7 |
ubiquitin protein ligase E3 component n-recognin 7 |
increases expression |
ISO |
kojic acid results in increased expression of UBR7 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 6:127,663,454...127,683,302
|
|
G |
Ufd1 |
ubiquitin recognition factor in ER associated degradation 1 |
increases expression |
ISO |
kojic acid results in increased expression of UFD1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr11:95,665,971...95,689,423
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of UGT1A2 mRNA |
CTD |
PMID:17917374 |
|
NCBI chr 9:96,239,019...96,256,264
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of UGT1A6 mRNA |
CTD |
PMID:18544905 |
|
NCBI chr 9:96,195,018...96,256,264
|
|
G |
Unc5c |
unc-5 netrin receptor C |
decreases expression |
ISO |
kojic acid results in decreased expression of UNC5C mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:232,854,352...233,208,482
|
|
G |
Ung |
uracil-DNA glycosylase |
multiple interactions |
ISO |
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of UNG mRNA |
CTD |
PMID:17917374 |
|
NCBI chr12:48,145,838...48,154,789
|
|
G |
Usp1 |
ubiquitin specific peptidase 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of USP1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:118,703,056...118,714,426
|
|
G |
Usp44 |
ubiquitin specific peptidase 44 |
decreases expression |
ISO |
kojic acid results in decreased expression of USP44 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:30,251,142...30,301,185
|
|
G |
Utp11 |
UTP11, small subunit processome component |
increases expression |
ISO |
kojic acid results in increased expression of UTP11 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:142,215,974...142,230,859
|
|
G |
Wnt10a |
Wnt family member 10A |
decreases expression |
ISO |
kojic acid results in decreased expression of WNT10A mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 9:83,798,594...83,811,060
|
|
G |
Yeats2 |
YEATS domain containing 2 |
increases expression |
ISO |
kojic acid results in increased expression of YEATS2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr11:94,247,538...94,333,652
|
|
G |
Zc3h15 |
zinc finger CCCH-type containing 15 |
decreases expression |
ISO |
kojic acid results in decreased expression of ZC3H15 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 3:89,151,432...89,171,203
|
|
G |
Zdhhc20 |
zinc finger DHHC-type palmitoyltransferase 20 |
decreases expression |
ISO |
kojic acid results in decreased expression of ZDHHC20 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr15:36,095,624...36,154,546
|
|
G |
Zfand1 |
zinc finger AN1-type containing 1 |
decreases expression |
ISO |
kojic acid results in decreased expression of ZFAND1 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 2:93,351,918...93,364,959
|
|
G |
Zfp146 |
zinc finger protein 146 |
decreases expression |
ISO |
kojic acid results in decreased expression of ZNF146 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:94,537,054...94,549,315
|
|
G |
Zfp414 |
zinc finger protein 414 |
decreases expression |
ISO |
kojic acid results in decreased expression of ZNF414 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 7:15,122,408...15,125,115
|
|
G |
Zfp438 |
zinc finger protein 438 |
increases expression |
ISO |
kojic acid results in increased expression of ZNF438 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr17:57,121,637...57,242,892
|
|
G |
Zfp483 |
zinc finger protein 483 |
decreases expression |
ISO |
kojic acid results in decreased expression of ZNF483 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 5:78,558,213...78,575,559
|
|
G |
Zkscan8 |
zinc finger with KRAB and SCAN domains 8 |
decreases expression |
ISO |
kojic acid results in decreased expression of ZKSCAN8 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr17:47,735,120...47,753,126
|
|
G |
Zmynd15 |
zinc finger, MYND-type containing 15 |
decreases expression |
ISO |
kojic acid results in decreased expression of ZMYND15 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr10:55,669,832...55,676,446
|
|
G |
Zp2 |
zona pellucida glycoprotein 2 |
decreases expression |
ISO |
kojic acid results in decreased expression of ZP2 mRNA |
CTD |
PMID:16595896 |
|
NCBI chr 1:183,944,840...183,956,619
|
|